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Abstract
In 2009, a working group of the International Agency for Research on Cancer classified formaldehyde as
carcinogenic to humans (Group 1) and concluded that formaldehyde causes cancer of the nasopharynx (NPC)
and leukemia. The results of a large cohort study of industrial workers exposed to formaldehyde, conducted by the
U.S. National Cancer Institute, mainly contributed to the available body of epidemiologic evidence. In their recent
updated re-analysis of these cohort data published in your journal, Dr Marsh and his colleagues concluded that the
results of the original analysis of NPC-risk are misleading because they are based on inappropriate regression
analyses. In our view the reason for the elevated NPC risk reported in the original analysis might be also another
one - a diagnostic bias. Therefore, it would be very helpful if the authors provided results for all other sub-categories
(as three-digit categories of the International Classification of Diseases) of the pharynx to verify the hypothesis
described and, hence, to clarify the relationship between exposure to formaldehyde and the risk of NPC.
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Dear Editor,
In 2009, a working group of the International Agency
for Research on Cancer classified formaldehyde (FA) as
carcinogenic to humans (Group 1) and concluded that
FA causes cancer of the nasopharynx (NPC) and
leukemia [1]. The results of a large cohort study of
industrial workers exposed to FA, conducted by the U.S.
National Cancer Institute (NCI) [2, 3], mainly contrib-
uted to the available body of epidemiologic evidence. In
their recent updated re-analysis of these cohort data
published in your journal, Dr Marsh and his colleagues
concluded that the results of the original analysis of
NPC-risk are misleading because they are based on
inappropriate regression analyses and that their updated
re-analysis did not support NCI’s suggestion of a persist-
ent association between FA exposure and NPC risk [4].
In our view the reason for the elevated NPC risk
reported in the original analysis might be also another
one. With regard to the International Classification of
Diseases (ICD), the pharynx is the only entity for which
the share of cases classified as “not specified” (PCns) is
of relevant magnitude. Taking the data from the
Connecticut Cancer Registry – the state where the study
plants are located – for the period from 2003 until 2007
and comparing the data on incidence with the corre-
sponding mortality data results in a ratio of mortality to
incidence (M/I) of 2.62 for PCns (Table 1). Moreover,
the number of deaths for which NPC was stated as the
underlying cause was much lower than the number of
deaths for which PCns was the underlying cause. To
verify this relationship we asked the Common Cancer
Registry of the six eastern states of Germany to provide
us with corresponding data for a certain period. Analyses
for the years 2005 and 2006 indicated that M/I was in
the same direction but not as pronounced as for
Connecticut: 0.4 and 1.25 for NPC and PCns, respect-
ively [personal communication with Roland Stabenow
and Brigitte Streller from the Common Cancer Registry
(Gemeinsames Krebsregister), Berlin, January 2016]. The
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reason for such a large difference might be the difficulty
to get the specific diagnosis especially if the individual
died at home. Hence, using nasopharynx as a single
entity in a mortality study might introduce a strong
diagnostic bias. A better approach would be to use the
whole pharynx (ICD-8: 146–149; ICD-10: C09-C14), at
least for mortality-based studies.
The results of the primary analysis of the first follow-
up [5] support our hypothesis. Only one case was
observed for pharynx, unspecified (ICD-8: 149), whereas
4.4 cases were expected, resulting in a SMR of 0.23 (95%
CI: 0.01 – 1.27). Hence, the relationship between the
number of cases for NPC and PCns in the cohort
followed up is quite different from that for the catch-
ment area of the cancer registry.
Combining observed and expected cases for the whole
pharynx from the first study report, no dose–response
relationship at all can be detected (Table 2). This state-
ment also holds true when NPC is combined with PCns
only (data not shown). Whereas the number of NPC
cases rose between first analysis and latest follow-up
only by about 50%, the number of cases for the whole
group buccal cavity and pharynx (ICD8: 140–149)
increased from 21 to 89 in this period. Therefore, it
would be very helpful if the authors provided results
for all other three-digit ICD-categories of the pharynx
to verify the hypothesis described and, hence, to
clarify the relationship between exposure to FA and
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Table 1 Incidence and Mortality 2003–2007, Connecticut, Males
Entity ICD-10 Incidencea UCDb MCDc M/Id
N AS(W)e N ASRf N ASRf
Tonsil C09 271 2.3 26 0.29 28 0.31 0.10
Other oropharynx C10 55 0.5 26 0.30 33 0.39 0.47
Nasopharynx C11 63 0.6 19 0.22 24 0.29 0.30
Hypopharynx C12-C13 128 1.1 18 0.21 21 0.25 0.14
Pharynx, unspecified C14 21 0.2 55 0.64 71 0.83 2.62
Nose, sinuses, etc. C30-C31 65 0.5 8 0.11 9 0.11 0.12
Pharynx C09-C14 538 4.7 144 1.66 177 2.07 0.27
a- from IARC (2014) Cancer in Five Continents, Vol. X
b- Underlying cause of death; from CDC, National Center for Health Statistics, Underlying Cause of Death 1999–2014 on CDC WONDER Online Database, released
2015. Accessed at https://wonder.cdc.gov/ucd-icd10.html on Jan 14, 2016
c- Multiple cause of death; from CDC, National Center for Health Statistics, Multiple Cause of Death 1999–2014 on CDC WONDER Online Database, released 2015.
Accessed at https://wonder.cdc.gov/mcd-icd10.html on Jan 14, 2016
d- Ratio between absolute numbers of cases for underlying cause of death and incidence
e- age-standardized rate (world population)
f- age-standardized rate (2000 U.S. Std. Population)
Table 2 Mortality from pharyngeal cancer by cumulative
exposure to formaldehyde (own calculations, based on data
from table 5 [5])
Cumulative exposure (ppm-years) OBS EXP SMR (95% CI)
0 (never) 2 1.1 1.82 (0.22 – 6.57)
(0.0, 0.5] 8 3.6 2.22 (0.96 – 4.38)
(0.5, 5.5] 3 4.1 0.73 (0.15 – 2.14)
(5.5, ∞) 2 2.6 0.77 (0.09 – 2.78)
>0 (ever) 13 10.3 1.26 (0.67 – 2.16)
OBS number of observed cases, EXP number of expected cases, SMR standardized
mortality ratio
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analysis of the mortality risk from nasopharyngeal cancer in the National
Cancer Institute formaldehyde worker cohort study. J Occup Med Toxicol.
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